Mechanistic description
Pathogenic gut bacteria prime peripheral macrophages through NLRP3 inflammasome activation, creating a systemic pro-inflammatory state that enhances neuroinflammation and dopaminergic neuron vulnerability. Selective inflammasome inhibitors combined with microbiome restoration could break this inflammatory cycle.
Mechanism / pathway
- NLRP3, CASP1, IL1B, PYCARD
- NLRP3 inflammasome activation
- neurodegeneration
Evidence for (5)
NLRP3 inflammasome in neuroinflammation and central nervous system diseases.
Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke.
NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING.
Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption.
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition.
Evidence against (3)
MCC950/NLRP3 inhibition has strong preclinical rationale but translational pharmacology and safety limitations remain unresolved for chronic neurodegenerative use.
A Parkinson NLRP3 inhibitor study focused on anti-inflammatory biomarker effects rather than demonstrated disease modification, leaving the clinical impact of inflammasome blockade uncertain.
Gut-inflammasome links are framed as axis-level physiology and pathology, but do not prove that bacterial inflammasome priming is the dominant driver of dopaminergic vulnerability.
Evidence matrix
Supporting
- NLRP3 inflammasome in neuroinflammation and central nervous system diseases. PMID:40075143 · 2025 · Cell Mol Immunol
- Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke. PMID:38701781 · 2024 · Cell Rep Med
- NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING. PMID:34497121 · 2021 · Proc Natl Acad Sci U S A
- Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption. PMID:36859349 · 2023 · J Neuroinflammation
- Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition. PMID:34367186 · 2021 · Front Immunol
Contradicting
- MCC950/NLRP3 inhibition has strong preclinical rationale but translational pharmacology and safety limitations remain unresolved for chronic neurodegenerative use. PMID:34117094 · 2021 · Pharmacol Rev
- A Parkinson NLRP3 inhibitor study focused on anti-inflammatory biomarker effects rather than demonstrated disease modification, leaving the clinical impact of inflammasome blockade uncertain. PMID:40792655 · 2025 · Mov Disord
- Gut-inflammasome links are framed as axis-level physiology and pathology, but do not prove that bacterial inflammasome priming is the dominant driver of dopaminergic vulnerability. PMID:33362788 · 2020 · Front Immunol
Top-ranked evidence
trust_score × relevance_score × exp(-recency_weight × recency_days / 365)
Supports · top 3
- #1 paper-f68ed030592f 0.466
- #2 paper-6643184baf5d 0.466
- #3 paper-e3e82982273c 0.466
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Microbial Inflammasome Priming Prevention. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-e7e1f943
@misc{scidex_hypothesis_he7e1f94,
title = {Microbial Inflammasome Priming Prevention},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-e7e1f943},
note = {SciDEX artifact hypothesis:h-e7e1f943}
}